The largest database of trusted experimental protocols

Lc30ad system

Manufactured by AB Sciex

The LC30AD System is a liquid chromatography system designed to perform high-performance liquid chromatography (HPLC) analysis. It consists of a pump, an autosampler, and a column oven, providing the essential components for separation and analysis of liquid samples.

Automatically generated - may contain errors

2 protocols using lc30ad system

1

Plant Hormone Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
An amount of 0.15 g of fresh germinating seeds from each treatment was homogenized in 1 ml of 80% methanol solution and stored at 4°C for 12 h. The sample was treated by ultrasound in an ice bath for 30 min and then centrifuged at 12,000 rpm at 4°C for 5 min. A total of 800 μl of the extract was used to purify the supernatants under reduced pressure at room temperature, then reconstituted by adding 80 μl of 80% methanol solution and loaded in the SPE column (Welchrom C18 SPE, 00559-11001). The sample was then washed twice with 160 μl of distilled water to enrich the plant hormones and then washed twice with 160 μl of 5% methanol aqueous solution. After discarding the washing liquid, the residues were washed four times with 160 μl of methanol solution, and the methanol washing liquid was collected. Further drying was performed under reduced pressure, and 100 μl of methanol was added, then the generated extracts were used to measure the hormone contents by injecting 10 μl of sample into an AB SCIEX-Triple-TOF®-5600 + LC/MS/MS system (HPLC, Shimadzu LC30AD System, MS, AB Sciex TripleTOF 5600+).
+ Open protocol
+ Expand
2

Pharmacokinetics of NU6300 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male BALB/c mice were randomly divided into two groups (n = 3) to receive either intravenous (20 mg/kg) or intraperitoneal (20 mg/kg) administration of NU6300. Blood samples (20 μl each time) were collected from the posterior orbital venous plexus at 5, 15, and 30 min and 1, 2, 4, 6, 8, 10, and 24 hours after administration. Plasma samples were obtained by centrifugation (3500 rpm, 4°C, 15 min), and then the concentration of NU6300 in plasma was determined by LC-MS/MS analysis. Standard curve for NU6300 in plasma was generated by adding various concentrations, including an internal standard, to blank plasma. The Shimadzu LC-30 AD system was used for separation, with a mobile phase of ACN/0.1% formic acid at a flow rate of 0.5 ml/min. All blood samples were centrifuged and quantified using the Shimadzu LC-30 AD system coupled with AB SCIEX 5500 QTRAP mass spectrometer. Pharmacokinetic parameters were calculated using DAS 2.0.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!